Birchview Capital, LP
- SEC CIK
- 0001618205
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 60
- −3 vs. Q1 2022
- Portfolio value
- $137.5M
- −$1.43M (−1.0%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SIENProject Sage Oldco, Inc. | COM | 40,000 | $34.0K | <0.1% | 00.0% | Unchanged | History |
| YTENYIELD10 Bioscience, Inc. | COM | 18,750 | $42.0K | <0.1% | 00.0% | Unchanged | History |
| AWHLAspira Women's Health Inc. | COM | 83,104 | $49.0K | <0.1% | −20,000−19.4% | Reduced | History |
| LSFLaird Superfood, Inc. | COM STK | 28,000 | $53.0K | <0.1% | 00.0% | Unchanged | History |
| ELTXElicio Therapeutics, Inc. | COM | 54,392 | $62.0K | <0.1% | 00.0% | Unchanged | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 20,000 | $84.0K | 0.1% | 00.0% | Unchanged | History |
| IFRXInflaRx N.V. | COM | 70,000 | $102.0K | 0.1% | 00.0% | Unchanged | History |
| ISEEIVERIC bio, Inc. | COM | 15,000 | $144.0K | 0.1% | 00.0% | Unchanged | History |
| STOKStoke Therapeutics, Inc. | COM | 15,000 | $198.0K | 0.1% | 00.0% | Unchanged | History |
| GTHXG1 Therapeutics, Inc. | COM | 40,000 | $198.0K | 0.1% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 20,000 | $212.0K | 0.2% | 00.0% | Unchanged | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 8,000 | $225.0K | 0.2% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 30,000 | $291.0K | 0.2% | 00.0% | Unchanged | History |
| PTGXProtagonist Therapeutics, Inc | COM | 38,000 | $301.0K | 0.2% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 10,000 | $304.0K | 0.2% | +10,000 | New | History |
| XNCRXencor Inc | COM | 12,300 | $337.0K | 0.2% | 00.0% | Unchanged | History |
| SILKSilk Road Medical Inc | COM | 10,000 | $364.0K | 0.3% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 40,000 | $394.0K | 0.3% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 33,000 | $404.0K | 0.3% | +8,000+32.0% | Added | History |
| BLUEbluebird bio, Inc. | COM | 98,000 | $406.0K | 0.3% | +14,000+16.7% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 38,000 | $408.0K | 0.3% | 00.0% | Unchanged | History |
| IRTCiRhythm Holdings, Inc. | COM | 4,000 | $432.0K | 0.3% | 00.0% | Unchanged | History |
| NKTRNektar Therapeutics | COM | 128,000 | $486.0K | 0.4% | 00.0% | Unchanged | History |
| ChemoCentryx, Inc.16383L106 | COM | 20,000 | $496.0K | 0.4% | 00.0% | Unchanged | – |
| APLSApellis Pharmaceuticals, Inc. | COM | 12,000 | $543.0K | 0.4% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 45,114 | $578.0K | 0.4% | 00.0% | Unchanged | History |
| TPTXTurning Point Therapeutics, Inc. | COM | 8,000 | $602.0K | 0.4% | 00.0% | Unchanged | History |
| CFRXCONTRAFECT Corp | COM | 200,000 | $614.0K | 0.4% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 15,000 | $631.0K | 0.5% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 150,000 | $675.0K | 0.5% | −40,000−21.1% | Reduced | History |
| NARIInari Medical, Inc. | Stock | 10,000 | $680.0K | 0.5% | +2,000+25.0% | Added | History |
| SLNOSoleno Therapeutics Inc | COM | 3,676,899 | $680.0K | 0.5% | 00.0% | Unchanged | History |
| DCGODocGo Inc. | COM | 110,000 | $785.0K | 0.6% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 59,833 | $790.0K | 0.6% | +25,500+74.3% | Added | History |
| INBXInhibrx Biosciences, Inc. | COM | 70,448 | $800.0K | 0.6% | +20,000+39.6% | Added | History |
| ETRNMidstream Co LLC | COM | 133,050 | $846.0K | 0.6% | 00.0% | Unchanged | History |
| PXDPioneer Natural Resources Co | COM | 3,800 | $848.0K | 0.6% | 00.0% | Unchanged | History |
| AVEOAveo Pharmaceuticals, Inc. | COM NEW | 140,000 | $918.0K | 0.7% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 25,000 | $982.0K | 0.7% | 00.0% | Unchanged | History |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $1.19M | 0.9% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 269,332 | $1.22M | 0.9% | 00.0% | Unchanged | History |
| HROWHarrow, Inc. | COM | 180,000 | $1.31M | 1.0% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 159,088 | $1.33M | 1.0% | +30,000+23.2% | Added | History |
| ALKSAlkermes plc. | SHS | 50,000 | $1.49M | 1.1% | 00.0% | Unchanged | History |
| MASIMasimo Corp | COM | 15,280 | $2.00M | 1.5% | +6,000+64.7% | Added | History |
| PHRPhreesia, Inc. | COM | 82,700 | $2.07M | 1.5% | +72,700+727.0% | Added | History |
| BHVNBiohaven Ltd. | COM | 15,000 | $2.19M | 1.6% | +1,000+7.1% | Added | History |
| AXDXAccelerate Diagnostics, Inc | COM | 2,252,388 | $2.24M | 1.6% | 00.0% | Unchanged | History |
| ALBOAlbireo Pharma, Inc. | COM | 113,000 | $2.24M | 1.6% | 00.0% | Unchanged | History |
| CLRContinental Resources, Inc | COM | 38,600 | $2.52M | 1.8% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 102,548 | $2.78M | 2.0% | +60,570+144.3% | Added | History |
| BDSXBiodesix Inc | COM | 1,811,412 | $2.93M | 2.1% | +558,659+44.6% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 249,400 | $3.51M | 2.6% | +50,000+25.1% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 15,000 | $3.54M | 2.6% | −3,000−16.7% | Reduced | History |
| OVVOvintiv Inc. | COM | 84,200 | $3.72M | 2.7% | +50,000+146.2% | Added | History |
| FHTXFoghorn Therapeutics Inc. | COM | 284,843 | $3.87M | 2.8% | −9,300−3.2% | Reduced | History |
| QDELQuidelOrtho Corp | COM | 61,306 | $5.96M | 4.3% | +1,622+2.7% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 85,240 | $8.31M | 6.0% | −4,000−4.5% | Reduced | History |
| ELUTElutia Inc. | CL A COM | 1,418,123 | $10.0M | 7.3% | +2000.0% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 727,785 | $56.0M | 40.8% | −26,321−3.5% | Reduced | History |
Sold out since Q1 2022 (4)
Positions held at the end of Q1 2022 that are gone from this filing.
| Security | Class | Shares in Q1 2022 | Value in Q1 2022 | % of portfolio in Q1 2022 | History |
|---|---|---|---|---|---|
| BIIBBiogen Inc. | COM | 10,100 | $2.13M | 1.5% | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 300,000 | $987.0K | 0.7% | History |
| VNDAVanda Pharmaceuticals Inc. | COM | 50,000 | $566.0K | 0.4% | History |
| AKBAAkebia Therapeutics, Inc. | COM | 20,000 | $14.0K | <0.1% | History |